sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> central nervous system cns market

report

Central Nervous System (CNS) Market, by Neurological Disorders (Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Brain Tumor, Stroke), Mental Disorders (Anxiety Disorder, Sleep Disorder, Mental Retardation, Multiple Sclerosis) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC189 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the central nervous system (CNS) market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the central nervous system (CNS) market. The scope of this report covers the central nervous system (CNS) market by its major segments, which include the neurological disorders, mental disorders, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the key factors propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

KEY PREMIUM INDUSTRY INSIGHTS

  • According to Alzheimer’s Association, as of 2016 5.4 million people are suffering from Alzheimer’s disease in America and these figures will triple up by 2050. It means, one in every nine people above the age of 65 has Alzheimer's disease. This is considered to be one of the major driving factors for the global central nervous system (CNS) market.
  • The rapidly increasing geriatric population and increasing age of baby boomers are creating a strong rise in the diseases such as Parkinson's, Alzheimer's, and various mental disorders. This is expected to drive the global market during the forecast period.
  • Limited availability of the medicines available for the treatment of the central nervous system-related diseases and disorders is one of the major growth drivers for the global central nervous system (CNS) market.
  • Pharmaceutical companies such as Novartis, Eli Lilly, and GlaxoSmithKline are making heavy investments to develop the most effective drugs for the complete cure of the CNS-related diseases and disorders, which is also considered as one of the growth drivers for this market during the next few years.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s central nervous system (CNS) market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the central nervous system (CNS) market by the following segments:

  • Central Nervous System  Market, by Neurological Disorders
    • Alzheimer’s Disease
    • Parkinson’s Disease
    • Epilepsy
    • Brain Tumor
    • Stroke
  • Central Nervous System Market, By Mental Disorders
    • Anxiety Disorder
    • Sleep Disorder
    • Mental Retardation
    • Multiple Sclerosis

KEY MARKET PLAYERS

Key players in the central nervous system (CNS) market include:

  • Novartis A.G.
  • Pfizer, Inc.
  • Johnson and Johnson
  • Eli Lilly and Company
  • Sanofi SA
  • Abbott Laboratories
  • Merck & Co.
  • Bristol Myers Squibb Company
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • UCB S.A.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Central Nervous System (CNS) Market

TRENDING RELATED REPORT

Medical Robotics Market, by Products (Robotic Systems, Assistive, Therapeutic, Orthotics, Prosthetics, Exoskeleton, Neurosurgical, Orthopedic, Steerable, Pharmacy, Telemedicine), Applications (Cardiology, Laparoscopy, Neurology, Rehabilitation) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Pricing Analysis
    3. Regulatory Analysis
    4. Reimbursement Landscape
  5. CENTRAL NERVOUS SYSTEM  MARKET, BY NEUROLOGICAL DISORDERS
    1. Segment Share
    2. By Neurology Disorders
      1. Alzheimer's Disease
      2. Parkinson Disease
      3. Epilepsy
      4. Brain Tumor
      5. Stroke
  6. CENTRAL NERVOUS SYSTEM MARKET, BY MENTAL DISORDERS
    1. Segment Share
    2. By Mental Disorders
      1. Anxiety Disorder
      2. Sleep Disorder
      3. Mental Retardation
      4. Multiple Sclerosis
  7. CENTRAL NERVOUS SYSTEM MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Neurology Disorders
      3. By Mental Disorders
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Neurology Disorders
      3. By Mental Disorders
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Neurology Disorders
      3. By Mental Disorders
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Neurology Disorders
      3. By Mental Disorders
  8. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  9. KEY MARKET PLAYERS
    1. Novartis A.G
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Johnson and Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Sanofi SA
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8.  Bristol Myers Squibb Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Astellas Pharma Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. GlaxoSmithKline Plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    11. UCB S.A
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us